Xie, Q., He, W., Hu, W., Yang, L., Jiang, C., Kong, P., . . . Xia, L. (2018). Tumor-infiltrating lymphocyte as a prognostic biomarker in stage IV colorectal cancer should take into account the metastatic status and operation modality. Cancer Manag Res.
Chicago Style CitationXie, Qian-Kun, et al. "Tumor-infiltrating Lymphocyte As a Prognostic Biomarker in Stage IV Colorectal Cancer Should Take Into Account the Metastatic Status and Operation Modality." Cancer Manag Res 2018.
Cita MLAXie, Qian-Kun, et al. "Tumor-infiltrating Lymphocyte As a Prognostic Biomarker in Stage IV Colorectal Cancer Should Take Into Account the Metastatic Status and Operation Modality." Cancer Manag Res 2018.
Atenció: Aquestes cites poden no estar 100% correctes.